6-Ethyl-3-methyl-p-Chlorophenol | 18980-09-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 6-Ethyl-3-methyl-p-Chlorophenol
• 英文别名: 4-chloro-2-ethyl-5-methylphenol；2-ethyl-4-chloro-5-methyl-phenol；2-Aethyl-4-chlor-5-methyl-phenol；6-Chlor-3-hydroxy-1-methyl-4-aethyl-benzol；6-Ethyl-3-methyl p-Chlorophenol；4-Chloro-3-methyl-6-ethylphenol
• CAS: 18980-09-1
• 化学式: C₉H₁₁ClO
• 分子量: 170.639
• InChiKey: ZSTDEWVWZHPUCW-UHFFFAOYSA-N

物化性质

• 熔点：
  73 °C(Solv: ligroine (8032-32-4))
• 沸点：
  252.8±35.0 °C(Predicted)
• 密度：
  1.145±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  5'-氯-2'-羟基-4'-甲基苯乙酮 在 盐酸 、 amalgamated zinc 作用下， 生成 6-Ethyl-3-methyl-p-Chlorophenol
  参考文献：
  名称：

  The Alkyl Derivatives of Halogen Phenols and their Bactericidal Action. I. Chlorophenols

  摘要：

  DOI：

  10.1021/ja01333a058

文献信息

• 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS
  申请人：Tansna Therapeutics Inc.

  公开号：US20150148430A1

  公开（公告）日：2015-05-28

  The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of Formula (I): wherein R 2 , R 4 , & R 5 , are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating neurological conditions.

  本公开提供用于治疗诸如惊厥和震颤等神经学状况的酚类化合物，其具有公式（I）的结构： 其中R2、R4和R5如详细描述中定义；包含至少一种该化合物的药物组合物；以及用于治疗神经学状况的方法。
• [EN] 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS<br/>[FR] COMPOSÉS 2,5-DIALKYL-4-H/HALO/ÉTHER-PHÉNOL
  申请人：TANSNA THERAPEUTICS INC

  公开号：WO2016190871A1

  公开（公告）日：2016-12-01

  The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of Formula (I): wherein R2, R4, R5, & R6, are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating neurological conditions.

  本公开提供了对神经系统疾病如抽搐和震颤有用的酚类化合物，其结构如下式（I）：其中R2、R4、R5和R6如详细描述中所定义；包括至少一种该化合物的药物组合物；以及治疗神经系统疾病的方法。
• [EN] METHODS AND COMPOSITIONS COMPRISING GUANIDINES FOR TREATING BIOFILMS<br/>[FR] MÉTHODES ET COMPOSITIONS COMPRENANT DES GUANIDINES DESTINÉS AU TRAITEMENT DE BIOFILMS
  申请人：HARVARD COLLEGE

  公开号：WO2014078801A1

  公开（公告）日：2014-05-22

  Methods of treating or reducing biofilms, treating a biofilm-related disorder, triggering biofilm disassembly, and preventing biofilm formation using guanidines is described.

  描述了使用胍类物质治疗或减少生物膜、治疗与生物膜有关的疾病、促使生物膜解体以及预防生物膜形成的方法。
• Silver dihydrogen citrate compositions
  申请人：Arata B. Andrew

  公开号：US20060051430A1

  公开（公告）日：2006-03-09

  Personal care and home care compositions are disclosed, which include silver dihydrogen citrate. The inventive compositions advantageously take the form of suspensions, pastes, liquids and gels. The inventive compositions also optionally comprise additional ingredients, and are therefore suitable for a wide variety of personal, home and industrial care purposes.

  护理和家居用品组合物被披露，其中包括柠檬酸二氢银。这种创新的组合物有利地采用悬浮液、糊状物、液体和凝胶的形式。这些创新的组合物还可以选择性地包含额外的成分，因此适用于各种个人、家庭和工业护理用途。
• [EN] AGRICULTURAL APPLICATIONS OF SILVER DIHYDROGEN CITRATE<br/>[FR] APPLICATIONS AGRICOLES DU DIHYDROGÉNOCITRATE D'ARGENT
  申请人：PURE BIOSCIENCE

  公开号：WO2009148469A1

  公开（公告）日：2009-12-10

  A method for treating a plant, the method comprising contacting a composition comprising silver dihydrogen citrate with at least one of the plant, a portion of soil and/or groundwater proximal to the plant, or a combination thereof.

  一种治疗植物的方法，该方法包括将含有双氢柠檬酸银的组合物与植物之一、植物附近的土壤和/或地下水的部分，或两者的组合物接触。